{"id":"W2034014431","doi":"10.2165/11588350-000000000-00000","title":"Adjuvant Trastuzumab for Breast Cancer","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Nova Scotia Cancer Centre; Atlantic School of Theology; Cancer Care Nova Scotia; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Trastuzumab; Breast cancer; Adjuvant; Quality of Life Research; Medicine; Oncology; Health economics; Internal medicine; Public health; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002363901,0.0001439293,0.0002804989,0.0000845444,0.00005818202,0.00001319654,0.000164978,0.00005420018,0.006837397],"category_scores_gemma":[0.000009946561,0.0001387364,0.0001248876,0.00005558795,0.00006933795,0.00009509296,0.00004020196,0.0001883246,0.0001893531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004130828,"about_ca_system_score_gemma":0.0004235091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003014517,"about_ca_topic_score_gemma":0.0000358531,"domain_scores_codex":[0.9989254,0.00001458504,0.0002572573,0.0003006905,0.00008403495,0.000418003],"domain_scores_gemma":[0.9992984,0.00004085813,0.0000594669,0.0002178373,0.0000995288,0.0002839088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00455405,0.0007020192,0.0470043,0.0008132072,0.0007242264,0.00004967341,0.00222603,0.00003212882,0.02240042,0.001143678,0.1367271,0.7836232],"study_design_scores_gemma":[0.01998586,0.0008736315,0.1050732,0.0002316579,0.0007824557,0.0005492182,0.0004912229,0.01828134,0.2261587,0.001230112,0.6251389,0.001203741],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.951658,0.001734396,0.0008799535,0.006279948,0.002213575,0.002628274,0.001918642,0.0002260997,0.03246112],"genre_scores_gemma":[0.9922938,0.001018273,0.001387374,0.00243714,0.0008831628,0.0004650306,0.00001552448,0.00007188797,0.00142786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7824194,"threshold_uncertainty_score":0.9940705,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1428086307434459,"score_gpt":0.4348955413737136,"score_spread":0.2920869106302676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}